MYX 1.00% $3.95 mayne pharma group limited

Ann: MYX completes TherapeuticsMD product licensing transaction, page-43

  1. 917 Posts.
    lightbulb Created with Sketch. 335
    Your entitled to disagree BUT what you dont understand is that MYX have been going down this road of breaking the traditional sales avenues for a number of years. They appear to have invested a lot of money in systems to connect the parties involved, stock and ship the goods, and do it well.
    If you dont like it then sell your shares. Thats where MYX has been and is headed. MYX will try to become the sales agents and suppliers for as many products as possible that fit their sales infrastructure. virtually nobody would have sufficient product to pay for such a large sales force. Perhaps you could share some detailed knowledge on why this system is "hopeless". The Board seem to have adopted it. Even an amateur like me can see this sales model could be fantastic - and an alternative to putting your product with the 3 large suppliers to the american market at NO PROFIT.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.